Eagle Health Investments LP's Q2 2024 13F: 3 new positions, 5 exits
Form 13F-HR for the quarter ended Jun 30, 2024 · filed Aug 13, 2024 · 25 reported positions · accession 0001172661-24-003270
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| New | UNITEDHEALTH GROUP INC (UNH) | — | 7.9% | +7.9 pts | +86,900 sh | new |
| New | INSMED INC (INSM) | — | 6.2% | +6.2 pts | +514K sh | new |
| Exited | DANAHER CORPORATION (DHR) | 5.4% | — | −5.4 pts | −114K sh | −100% |
| Reduced | TRANSMEDICS GROUP INC (TMDX) | 3.9% | 3.6% | −0.3 pts | −146K sh | −52% |
| New | BIOMARIN PHARMACEUTICAL INC (BMRN) | — | 3.4% | +3.4 pts | +232K sh | new |
| Increased | EXACT SCIENCES CORP (EXAS) | 1.6% | 4.1% | +2.5 pts | +423K sh | +350% |
| Reduced | NATERA INC (NTRA) | 11.0% | 9.2% | −1.9 pts | −159K sh | −25% |
| Exited | SAREPTA THERAPEUTICS INC (SRPT) | 2.5% | — | −2.5 pts | −103K sh | −100% |
| Exited | FUSION PHARMACEUTICALS INC (FUSN) | 2.4% | — | −2.4 pts | −580K sh | −100% |
| Increased | ULTRAGENYX PHARMACEUTICAL IN (RARE) | 2.7% | 3.9% | +1.2 pts | +225K sh | +75% |
| Exited | PACIFIC BIOSCIENCES CALIF IN (PACB) | 1.5% | — | −1.5 pts | −2.17M sh | −100% |
| Increased | ALNYLAM PHARMACEUTICALS INC (ALNY) | 1.4% | 3.3% | +1.9 pts | +27,900 sh | +58% |
| Exited | 10X GENOMICS INC (TXG) | 1.0% | — | −1.0 pts | −135K sh | −100% |
| Reduced | PROCEPT BIOROBOTICS CORP (PRCT) | 3.2% | 2.8% | −0.4 pts | −80,129 sh | −24% |
| Reduced | UNITED THERAPEUTICS CORP DEL (UTHR) | 7.9% | 9.5% | +1.7 pts | −12,000 sh | −7% |
| Reduced | INTUITIVE SURGICAL INC (ISRG) | 2.7% | 2.2% | −0.5 pts | −7,300 sh | −21% |
| Reduced | GUARDANT HEALTH INC (GH) | 2.9% | 3.2% | +0.4 pts | −103K sh | −14% |
| Increased | INSPIRE MED SYS INC (INSP) | 5.0% | 3.3% | −1.7 pts | +14,400 sh | +12% |
| Increased | ARGENX SE (ARGX) | 6.3% | 6.8% | +0.5 pts | +4,300 sh | +5% |
| Reduced | DEXCOM INC (DXCM) | 7.5% | 5.6% | −1.9 pts | −9,200 sh | −3% |
| New |
GRAIL INC (GRAL)
new — newly listed security (e.g. spin-off)
|
— | 0.1% | +0.1 pts | +53,124 sh | new |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 68.2% of the equity book
Changes in the top 10 this quarter: UNH entered · INSM entered · EXAS entered · DHR left · INSP left · TMDX left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | UNITED THERAPEUTICS CORP DEL (UTHR) | 7.9% | 9.5% | |
| 2 | NATERA INC (NTRA) | 11.0% | 9.2% | |
| 3 | ICON PLC (ICLR) | 9.6% | 8.4% | |
| 4 | UNITEDHEALTH GROUP INC (UNH) | 0.0% | 7.9% | Entered the top 10 |
| 5 | ARGENX SE (ARGX) | 6.3% | 6.8% | |
| 6 | INSMED INC (INSM) | 0.0% | 6.2% | Entered the top 10 |
| 7 | ILLUMINA INC (ILMN) | 8.3% | 5.9% | |
| 8 | DEXCOM INC (DXCM) | 7.5% | 5.6% | |
| 9 | IQVIA HLDGS INC (IQV) | 5.9% | 4.6% | |
| 10 | EXACT SCIENCES CORP (EXAS) | 1.6% | 4.1% | Entered the top 10 |
| — | DANAHER CORPORATION (DHR) | 5.4% | 0.0% | Left the top 10 |
| — | INSPIRE MED SYS INC (INSP) | 5.0% | 3.3% | Left the top 10 |
| — | TRANSMEDICS GROUP INC (TMDX) | 3.9% | 3.6% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).